In the last 12 months, insiders at ArriVent BioPharma, Inc. ($AVBP) filed 64 transactions with the SEC: 6 open-market purchases totaling $33,999,966 and 1 sales totaling $12,983,320. Net insider sentiment: net buying.
ArriVent BioPharma, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. (TenPercentOwner) — 6 transactions totaling $22,983,310
- GORDON CARL L (Director) — 10 transactions totaling $7,999,992
- ORBIMED ADVISORS LLC (Director) — 10 transactions totaling $7,999,992
- HEALY JAMES (Director) — 3 transactions totaling $7,999,992
- LaChapelle Robin (Chief Operating Officer) — 18 transactions totaling $115,910
View all SEC Filings for ArriVent BioPharma, Inc. (AVBP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Yao Zhengbin | President and CEO | A | Stock Option (right to buy) | 550000 | $0.00 | 550,000.0000 | 38,462,600 | 9999.99% | 1.43% |
| Feb. 2, 2026 | Kung Winston | Chief Financial Officer | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 38,462,600 | 9999.99% | 0.36% |
| Feb. 2, 2026 | Lutzker Stuart | President of R&D | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 38,462,600 | 9999.99% | 0.39% |
| Feb. 2, 2026 | LaChapelle Robin | Chief Operating Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 38,462,600 | 9999.99% | 0.34% |
| Feb. 2, 2026 | Kastenmayer James Paul | General Counsel | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 38,462,600 | 9999.99% | 0.34% |
| Dec. 10, 2025 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | S | Common Stock | 555555 | $23.37 | 3,929,117.0000 | 41,912,905 | 12.39% | 1.33% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 6503 | $0.00 | 6,370.0000 | 35,006,114 | 50.52% | 0.02% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2600 | $0.00 | 12,873.0000 | 35,006,114 | 16.80% | 0.01% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2050 | $2.28 | 521,110.0000 | 35,006,114 | 0.39% | 0.01% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2600 | $2.28 | 523,710.0000 | 35,006,114 | 0.50% | 0.01% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 6503 | $2.28 | 530,213.0000 | 35,006,114 | 1.24% | 0.02% |
| July 11, 2025 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2050 | $0.00 | 410.0000 | 35,006,114 | 83.33% | 0.01% |
| June 18, 2025 | Nolet Chris | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| June 18, 2025 | Hohneker John | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| June 18, 2025 | Peterson Kristine | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| June 18, 2025 | Parsey Merdad | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| April 28, 2025 | Parsey Merdad | Director | A | Stock Option (right to buy) | 28346 | $0.00 | 28,346.0000 | 33,898,870 | 9999.99% | 0.08% |
| Feb. 3, 2025 | Yao Zhengbin | President and CEO | A | Stock Option (right to buy) | 380000 | $0.00 | 380,000.0000 | 31,469,328 | 9999.99% | 1.21% |
| Feb. 3, 2025 | Lutzker Stuart | President of R&D | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 31,469,328 | 9999.99% | 0.38% |
| Feb. 3, 2025 | LaChapelle Robin | Chief Operating Officer | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 31,469,328 | 9999.99% | 0.38% |
| Feb. 3, 2025 | Kung Winston | Chief Financial Officer | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 31,469,328 | 9999.99% | 0.38% |
| Feb. 3, 2025 | Kastenmayer James Paul | General Counsel | A | Stock Option (right to buy) | 102000 | $0.00 | 102,000.0000 | 31,469,328 | 9999.99% | 0.32% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2471 | $0.00 | 2,460.0000 | 33,502,347 | 50.11% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2867 | $0.00 | 22,637.0000 | 33,502,347 | 11.24% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 7164 | $0.00 | 15,473.0000 | 33,502,347 | 31.65% | 0.02% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 12364 | $0.00 | 18,865.0000 | 33,502,347 | 39.59% | 0.04% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Stock Option (right to buy) | 2700 | $0.00 | 56,471.0000 | 33,502,347 | 4.56% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2867 | $2.28 | 497,061.0000 | 33,502,347 | 0.58% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2700 | $6.24 | 494,194.0000 | 33,502,347 | 0.55% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 12364 | $3.65 | 519,060.0000 | 33,502,347 | 2.44% | 0.04% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 2471 | $2.28 | 506,696.0000 | 33,502,347 | 0.49% | 0.01% |
| Sept. 19, 2024 | LaChapelle Robin | Chief Operating Officer | M | Common Stock | 7164 | $2.28 | 504,225.0000 | 33,502,347 | 1.44% | 0.02% |
| May 16, 2024 | Hohneker John | Director | A | Stock Option (right to buy) | 29550 | $0.00 | 29,550.0000 | 25,046,531 | 9999.99% | 0.12% |
| April 22, 2024 | Peterson Kristine | Director | A | Stock Option (right to buy) | 28587 | $0.00 | 28,587.0000 | 25,046,531 | 9999.99% | 0.11% |
| Jan. 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | C | Series B Preferred Stock | 4761903 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 100.00% |
| Jan. 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | C | Common Stock | 3616041 | $0.00 | 3,616,041.0000 | 2,140,951 | 9999.99% | 100.00% |
| Jan. 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | C | Common Stock | 313076 | $0.00 | 3,929,117.0000 | 2,140,951 | 8.66% | 14.62% |
| Jan. 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | P | Common Stock | 555555 | $18.00 | 4,484,672.0000 | 2,140,951 | 14.14% | 25.95% |
| Jan. 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | TenPercentOwner | C | Series A Preferred Stock | 55000000 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 100.00% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Common Stock | 821827 | $0.00 | 821,827.0000 | 2,140,951 | 9999.99% | 38.39% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Series A Preferred Stock | 821827 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 38.39% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Series B Preferred Stock | 469615 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 21.94% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Series B Preferred Stock | 469615 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 21.94% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Common Stock | 821827 | $0.00 | 821,827.0000 | 2,140,951 | 9999.99% | 38.39% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Common Stock | 821827 | $0.00 | 821,827.0000 | 2,140,951 | 9999.99% | 38.39% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Common Stock | 469615 | $0.00 | 1,291,442.0000 | 2,140,951 | 57.14% | 21.94% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Common Stock | 469615 | $0.00 | 1,291,442.0000 | 2,140,951 | 57.14% | 21.94% |
| Jan. 30, 2024 | GORDON CARL L | Director | P | Common Stock | 222222 | $18.00 | 1,513,664.0000 | 2,140,951 | 17.21% | 10.38% |
| Jan. 30, 2024 | GORDON CARL L | Director | P | Common Stock | 222222 | $18.00 | 1,513,664.0000 | 2,140,951 | 17.21% | 10.38% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Series A Preferred Stock | 821827 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 38.39% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Series A Preferred Stock | 821827 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 38.39% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Series B Preferred Stock | 469615 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 21.94% |
| Jan. 30, 2024 | GORDON CARL L | Director | C | Series B Preferred Stock | 469615 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 21.94% |
| Jan. 30, 2024 | HEALY JAMES | Director | C | Common Stock | 1252308 | $0.00 | 1,252,308.0000 | 2,140,951 | 9999.99% | 58.49% |
| Jan. 30, 2024 | HEALY JAMES | Director | P | Common Stock | 444444 | $18.00 | 1,696,752.0000 | 2,140,951 | 35.49% | 20.76% |
| Jan. 30, 2024 | HEALY JAMES | Director | C | Series B Preferred Stock | 1252308 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 58.49% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Common Stock | 821827 | $0.00 | 821,827.0000 | 2,140,951 | 9999.99% | 38.39% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Series A Preferred Stock | 821827 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 38.39% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 222222 | $18.00 | 1,513,664.0000 | 2,140,951 | 17.21% | 10.38% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 222222 | $18.00 | 1,513,664.0000 | 2,140,951 | 17.21% | 10.38% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Common Stock | 469615 | $0.00 | 1,291,442.0000 | 2,140,951 | 57.14% | 21.94% |
| Jan. 30, 2024 | ORBIMED ADVISORS LLC | Director | C | Common Stock | 469615 | $0.00 | 1,291,442.0000 | 2,140,951 | 57.14% | 21.94% |
| Jan. 25, 2024 | Nolet Chris | Director | A | Stock Option (right to buy) | 17884 | $0.00 | 17,884.0000 | 2,140,951 | 9999.99% | 0.84% |
| Jan. 25, 2024 | Jallal Bahija | Director | A | Stock Option (right to buy) | 17884 | $0.00 | 17,884.0000 | 2,140,951 | 9999.99% | 0.84% |